Health Care Costs

"Health Care Costs" Main

Latest Morning Briefing Stories

More Consumers Rolling Dice And Going With Bare Bones Plans As Substitute For ACA Coverage

KHN Morning Briefing

Most people who are going with the fixed indemnity plans — which aren’t considered true insurance under the health law — are healthy and willing to bet they won’t be hit with high medical bills anytime soon. Meanwhile, Democrats on Capitol Hill have introduced a public option plan that, though it has almost no chance of passing at the moment, reinforces the party’s push toward more universal coverage.

Fight Over Dialysis Payments Draws In The Big Guns

KHN Morning Briefing

Lawmakers in the California Senate health committee are set to vote Wednesday on a measure that would crack down on third-party premium assistance for dialysis patients. The bill has the backing of insurers and powerful labor groups.

Pharma’s Anti-Competitive Tactics That Stymie Generics Drugmakers Targeted By Officials, Lawmakers

KHN Morning Briefing

Generic drug developers need samples of brand-name drugs to show that a generic copy is equivalent to the original, but the drug companies are refusing to provide samples of their products. In other pharmaceutical news: an appeals court hands the industry a victory in price gouging case; a former Mallinckrodt employee claims she was fired for warning company about illegal sales practices; and a shortage of EpiPens outside the U.S.

When ‘Breakthrough’ Drugs Aren’t Actually Breakthroughs: FDA’s Approval Pathway Can Be Misleading, Study Finds

KHN Morning Briefing

A new paper finds that some drugs approved under a special law to bring “breakthrough” treatments to market faster are not actually significant scientific advances. In other pharmaceutical news: Sen. Cory Booker (D-N.J.) lashes out at drugmakers for using tax windfalls to help shareholders; insurers are starting to pass rebates directly on to consumers; and the SEC and the FDA both launch investigations into two different clinical trials.